AHA GUIDELINES Bundle (free trial)

Diagnosis and Management of Aortic Disease

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: http://eguideline.guidelinecentral.com/i/1483260

Contents of this Issue

Navigation

Page 97 of 97

Disclaimer is resource is for informational purposes only, intended as a quick-reference tool based on the cited source guideline(s), and should not be used as a substitute for the independent professional judgment of healthcare providers. Practice guidelines are unable to account for every individual variation among patients or take the place of clinician judgment, and the ultimate decision concerning the propriety of any course of conduct must be made by healthcare providers aer consideration of each individual patient situation. Guideline Central does not endorse any specific guideline(s) or guideline recommendations and has not independently verified the accuracy hereof. Any use of this resource or any other Guideline Central resources is strictly voluntary. Source Isselbacher EM, Preventza O, Black JH III, Augoustides JG, Beck AW, Bolen MA, Braverman AC, Bray BE, Brown-Zimmerman MM, Chen EP, Collins TJ, DeAnda A Jr, Fanola CL, Girardi LN, Hicks CW, Hui DS, Jones WS, Kalahasti V, Kim KM, Milewicz DM, Oderich GS, Ogbechie L, Promes SB, Ross EG, Schermerhorn ML, Times SS, Tseng EE, Wang GJ, Woo YJ. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines [published online ahead of print November 2, 2022]. J Am Coll Cardiol. doi: 10.1016/j.jacc.2022.08.004. Copublished in Circulation. doi: 10.1161/CIR.0000000000001106. AHAAOR10222c TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies at GuidelineCentral.com Copyright © 2022 All rights reserved GuidelineCentral.com Abbreviations 3D, 3-dimensional; AAA, abdominal aortic aneurysm; AAS, acute aortic syndrome; ACEI, angiotensin- converting enzyme inhibitor; AHI, aortic height index; AoD, aortic dissection; AR, aortic regurgitation; ARB, angiotensin receptor blocker; ARSA, aberrant right subclavian artery; AS, aortic stenosis; ASCA, aberrant subclavian artery; ASCVD, atherosclerotic cardiovascular disease; ASI, aortic size index; AVR, aortic valve replacement; BAAI, blunt traumatic abdominal aortic injury; BAV, bicuspid aortic valve; BP, blood pressure; BSA, body surface area; BTAI, blunt traumatic aortic injury; BTTAI, blunt traumatic thoracic aortic injury; CAD, coronary artery disease; CKD, chronic kidney disease; CMR, cardiac magnetic resonance; CoA, coarctation of the aorta; COPD, chronic obstructive pulmonary disease; COR, class of recommendation; csDMARD, conventional synthetic disease modifying antirheumatic drug ; CT, computed tomography; CTA, computed tomographic angiography; DAo, descending aorta; DBP, diastolic blood pressure; DMARD, disease-modifying anti-rheumatic drug ; ECG, electrocardiogram; EDS, Ehlers-Danlos syndrome; EVAR, endovascular abdominal aortic aneurysm repair; FDA, US Food and Drug Administration; FDG-PET, fluorodeoxyglucose–positron emission tomography; FEV1, forced expiratory volume in 1 second; FEVAR, fenestrated endovascular aortic repair; FID, focal intimal disruption; FTAA, familial thoracic aortic aneurysm (and dissection) syndrome; GC, glucocorticoids; GCA, giant cell arteritis; HRQOL, health-related quality of life; HTAD, heritable thoracic aortic disease; HTN, hypertension; ICU, intensive care unit; IMH, intramural hematoma; IRAD, International Registry of Acute Aortic Dissection; LCA, le common carotid artery; LDL, low- density lipoprotein; LDS, Loeys-Dietz syndrome; LOE, level of evidence; LSA, le subclavian artery; LVA, le vertebral artery; LVV, large vessel vasculitis; MFS, Marfan syndrome; MR, magnetic resonance; MRA, magnetic resonance angiography; MRI, magnetic resonance imaging ; MV, mitral valve; MVP, mitral valve prolapse; nsHTAD, nonsyndromic heritable thoracic aortic disease; PAD, peripheral artery disease; PAU, penetrating atherosclerotic ulcer; PDA, patent ductus arteriosus; PET, positron emission tomography; rAAA, ruptured abdominal aortic aneurysm; RCA, right common carotid artery; RCT, randomized controlled trial; REBOA, resuscitative endovascular balloon occlusion of the aorta; rEVAR, endovascular repair for rAAA; RSA, right subclavian artery; RVA, right vertebral artery; SBP, systolic blood pressure; SCI, spinal cord injury; SMA, superior mesenteric artery; STS, Society of oracic Surgeons; SVS, Society for Vascular Surgery; TAA, thoracic aortic aneurysm; TAAA, thoracoabdominal aortic aneurysm; TAAD, thoracic aortic aneurysm and dissection; TAD, thoracic aortic disease; TAR, total arch replacement; TEE, transesophageal echocardiography; TEVAR, thoracic endovascular aortic repair; TNF, tumor necrosis factor; TTE, transthoracic echocardiography; US, Ultrasound; vEDS, vascular Ehlers-Danlos syndrome; VSD, ventricular septal defect; VSRR, valve-sparing root replacement; VUS, variants of unknown significance; Y, year

Articles in this issue

Links on this page

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Diagnosis and Management of Aortic Disease